This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $460,279 in funding to Yale University to conduct research on "LOSS OF PROTEOSTASIS AND VASCULAR AMYLOIDOSIS". The award period runs from February 15, 2025 to February 14, 2027. As the prime awardee, Yale University will carry out this scientific research project focused on proteostasis and vascular amyloidosis. The funding supports Yale's expertise in areas like computational modeling, process development, and engineering across fields from virology to clean energy. Yale has also served as a subcontractor on federal grants, providing services such as statistical analysis, clinical trials support, curriculum development, and lab testing for agency research missions. This award is part of the Defense Health Agency's comprehensive Military Medical Research and Development program, which funds innovative biomedical research initiatives to improve health outcomes for military service members, veterans, and the broader public.
Generated 3/4/25, 8:42 AM